Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the FoF Domestic median (151 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 05 May 2014 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 500 history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | HSBC Multi Asset Active FOF |
|---|---|
| 05 May 2014 | ₹100.00 |
| 14 May 2015 | ₹122.27 |
| 22 May 2016 | ₹127.09 |
| 01 Jun 2017 | ₹155.46 |
| 10 Jun 2018 | ₹168.41 |
| 19 Jun 2019 | ₹171.43 |
| 27 Jun 2020 | ₹165.05 |
| 06 Jul 2021 | ₹234.06 |
| 15 Jul 2022 | ₹235.51 |
| 25 Jul 2023 | ₹280.86 |
| 02 Aug 2024 | ₹359.32 |
| 11 Aug 2025 | ₹379.30 |
| 20 Aug 2026 | ₹452.20 |
| Metric | HSBC · Direct NAV ₹45.33 Very High risk ★★★☆☆ | Category median FoF Domestic · 151 funds |
|---|---|---|
| +17.48% | +8.79% | |
| +17.11% | +14.76% | |
| +13.57% | +11.89% | |
| +12.50% | +12.34% | |
| +13.06% | +11.30% | |
| +15.57% | — | |
| +12.21% | +13.06% | |
| +11.76% | +10.96% | |
| +12.24% | +10.76% | |
| Risk | ||
| 11.24% | 15.95% | |
| 0.94 | 0.81 | |
| 1.29 | 1.14 | |
| -25.39% | -19.45% | |
| Nifty 500 | — | |
| +5.79% | +1.81% | |
| 0.67 | 0.94 | |
| 81.8% | 98.0% | |
| 39.0% | 93.1% | |
| 0.59% | 0.17% | |
| ₹106.68Cr | ₹228.08Cr | |
| 1.00% | — | |
| None | — | |
| ₹1.00K | — | |
| ₹5.00K | — | |
| 10% | 11% | |
| Gautam Bhupal · 10.8y | — | |
| 05 May 2014 | — | |
| — | — | |
| — | — | |
| 4.0% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.